By Julia Karow
This article was originally published Nov. 5.
Illumina said today that the Broad Institute has purchased 30 additional Genome Analyzer IIx systems, bringing its total to 89.
The new instruments will be used in whole-genome, exome, and transcriptome sequencing studies.
"We are happy with the technology's accuracy, ease of use, and scalability, as well as continued system improvements that have recently enabled us to generate multiple runs with more than 50 gigabases of high-quality sequence data," said Rob Nicol, director of sequencing operations at the Broad, in a statement issued by Illumina.
This is the second time this year that the Broad Institute has increased the number of Genome Analyzers at its genome center â€" in April, it said it was installing 22 additional instruments (see In Sequence 4/21/2009).
As of this spring, the institute also had 10 Roche/454 Genome Sequencers FLX, eight Applied Biosystems SOLiD systems, one Helicos Genetic Analysis System, and one Polonator installed.
In addition, the institute is currently testing Complete Genomics' human genome sequencing service as an early-access customer (see In Sequence 2/6/2009).